An overly conservative Bayesian analysis shows beyond a reasonable doubt that SARS-CoV-2 is laboratory derived. There’s a 99.8% probability SARS-CoV-2 came from a laboratory and only a 0.2% likelihood it came from nature
US securities regulators plan to require additional information from Chinese companies seeking to go public on American exchanges, saying the move will protect domestic investors.
